The self-expanding valve is not yet approved by the FDA, but care teams in other markets are reporting positive outcomes when patients go home the day after treatment. 

Both tirzepatide (Mounjaro) and semaglutide (Ozempic) have made headlines in recent months for their benefits in broad patient populations. This new analysis compared the two medications in obese/overweight adults with and without type 2 diabetes.

Adona Medical’s adjustable interatrial shunt can be made larger or smaller in size after implantation through the use of a custom-designed induction catheter.

Jim Melton, DO, a vascular surgeon in Oklahoma City, explains his efforts to reach patients in rural Oklahoma and Native American tribes with a mobile cardiovascular clinic program.

Patients with pulmonary hypertension are associated with increased short- and long-term risks of death following TAVR. Researchers emphasized the importance of learning as much as possible about this topic going forward. 

As one may expect, advances in TAVR and TMVR technologies are seen as key drivers of the market’s success.

According to a whistleblower, multiple Texas healthcare providers put complex heart surgeries in the hands of unqualified trainees without proper supervision. The $15M being recovered is the largest amount ever for a case of this kind. 

The new-look PFA system from Pulse Biosciences was designed to treat AFib with a single application that lasts less than two seconds.